Deborah Turner Kochevar
Known title: DirectorCIK: 0001448579
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CRL Analyst Targets Rise After UBS Reinstates Coverage. Charles River Laboratories saw its average analyst price target increase to $305.00, driven by UBS reinstating coverage with a $357.00 target. This move follows reports of stabilizing demand and increased interest in animal model markets. The stock is currently trading below its 52-week high, with technical indicators showing support near $181.76.
Transaction History
| ELAN | ▲ Buy | Grant | 4,678 | $0 | 5/21/2026 | View on chart |
| ELAN | ▲ Buy | Grant | 10,314 | $0 | 11/28/2025 | View on chart |
| ELAN | ▲ Buy | Grant | 18,169 | $0 | 11/29/2024 | View on chart |
| CRL | ▲ Buy | Grant | 559 | $128K | 5/13/2024 | View on chart |
| ELAN | ▲ Buy | Grant | 20,374 | $0 | 11/30/2023 | View on chart |
| CRL | ▲ Buy | Grant | 664 | $0 | 5/15/2023 | View on chart |
| ELAN | ▲ Buy | Grant | 18,649 | $0 | 11/30/2022 | View on chart |
| CRL | ▲ Buy | Grant | 575 | $0 | 5/11/2022 | View on chart |
| ELAN | ▲ Buy | Grant | 7,307 | $0 | 11/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Elanco (ELAN) Highlighted in Mid-Cap Stock Watchlist
Elanco was included in a recent Yahoo Finance article listing mid-cap stocks to monitor. The company is currently trading near its 52-week low, with an RSI of 38.5 indicating potential oversold conditions. Analysts maintain an average price target of $31.00, which is higher than the current trading level.
Elanco (ELAN) Highlighted in Mid-Cap Stock Watchlist. Elanco was included in a recent Yahoo Finance article listing mid-cap stocks to monitor. The company is currently trading near its 52-week low, with an RSI of 38.5 indicating potential oversold conditions. Analysts maintain an average price target of $31.00, which is higher than the current trading level.